Trevi Therapeutics TRVI
NASDAQ TRVI
$17.26 +0.20 (+1.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026)

Trevi Therapeutics (TRVI) posted quarterly Prepaid Assets of $2.1 million for Q1 2026, up 154.44% year-over-year from $834000.0 in Q1 2025, and up 68.01% quarter-over-quarter from $1.3 million in Q4 2025.

Analysis

Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026) Analysis & Trends

Trevi Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 154.44% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (up 154.44% YoY), while the FY2025 annual figure was $1.3 million, up 34.5% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $2.1 million, up from $1.3 million in the prior quarter.
  • The five-year high for Prepaid Assets was $4.0 million in Q3 2023, with the low at $477000.0 in Q1 2022.
  • The 5-year median for Prepaid Assets is $1.3 million (2025), against an average of $1.4 million.
  • The sharpest annual moves came in 2023 and 2024: Prepaid Assets surged 237.74% in 2023, then plunged 70.88% in 2024.
  • Trevi Therapeutics' Prepaid Assets stood at $795000.0 in 2022, then rose by 20.13% to $955000.0 in 2023, then declined by 1.68% to $939000.0 in 2024, then soared by 34.5% to $1.3 million in 2025, then surged by 68.01% to $2.1 million in 2026.
  • Business Quant data shows TRVI's Prepaid Assets at $2.1 million in Q1 2026, $1.3 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Trevi Therapeutics 2.71 Bn 2.71 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.26 Mn
Mar 31, 2026 2.22 Mn
Dec 31, 2025 2.13 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 1.77 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 939,000.00
Sep 30, 2024 1.18 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 3.23 Mn
Dec 31, 2023 3.62 Mn
Sep 30, 2023 4.04 Mn
Jun 30, 2023 2.98 Mn
Mar 31, 2023 1.61 Mn
Dec 31, 2022 1.31 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.65 Mn
Mar 31, 2022 477,000.00
Dec 31, 2021 886,000.00
Sep 30, 2021 1.39 Mn